Pharma & Drugs
Share your love
Steroid Treatment For Dry Eye Disease
Dry eye is related to the inflammation of ocular surface, and immune-mediated inflammation plays an important pathogenic role. Corticosteroid is an effective anti-inflammatory drug, which can rapidly and effectively relieve the symptoms and signs of moderate or severe dry eye.…
The Connection Between Blood Pressure and Glaucoma
Eye pressure varies separately from blood pressure. IOP management is not the same as blood pressure control. However, research has shown that those with high blood pressure are more likely to develop glaucoma. Glaucoma is not aided by extremely high…
AGTC-501 Offers Vision Gains for X-Linked RP
Inherited retinal diseases (IRDs), also referred to as inherited retinal dystrophies, are a clinically and genetically heterogeneous group of neurodegenerative disorders, primarily involving photoreceptors, retinal pigment epithelium (RPE), and/or the choroid. Taken as a whole, IRDs have an estimated global…
Preloaded IOL Injectors & Cataract Surgery
Preloaded injectors provide a number of benefits, including making the procedure safer by reducing the possibility of endophthalmitis from contamination and avoiding potential mistakes such as loading the lens incorrectly. It is certainly more efficient for the nursing or technical…
FDA Approves Cyclosporine Eye Drops
Verkazia 0.1%) eye drops containing cyclosporine have been authorized by the US Food and Drug Administration (FDA) for the treatment of vernal keratoconjunctivitis (VKC) in both adult and juvenile populations. The surface of the eyes in patients with the uncommon,…
TelomEYE Pharma Raises $1M in Post-Seed Funding
TelomEYE Pharmaceuticals Corporation, working on a new generation of ophthalmologic therapies, announced today the completion of a successful $1 million post-seed funding round, valuing the company at $10 million USD. The round was co-led by healthcare mogul Mehmet Ali Aydınlar,…
Jeff Farrow Becomes New CFO and CSO at Tarsus
Tarsus Pharmaceuticals has appointed Jeff Farrow as both Chief Financial Officer and Chief Strategy Officer, effective immediately. Farrow replaces Leo Greenstein, who had been CFO since 2020 but is leaving the company to pursue other professional interests. Farrow has over…
Bausch + Lomb Launches Ovd in the U.S.
Bausch + Lomb Corporation has recently launched the StableVisc™ cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc™ Viscoelastic System in the United States. These new products offer eye surgeons dual-action protection during cataract surgery, expanding the range of options available.…
Ocumension Submits NDA for Zerviate in China
Nicox SA announced that its exclusive Chinese partner, Ocumension Therapeutics, has submitted a new drug application (NDA) seeking approval for commercialization of Zerviate (cetirizine ophthalmic solution), 0.24%, in China. The intended use of Zerviate is for the treatment of ocular…
Tepezza Improves Proptosis in Patients With Chronic TED
Horizon Therapeutics has announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 clinical trial evaluating TEPEZZA for the treatment of adults with chronic thyroid eye disease (TED) and low CAS, a measure of disease activity.…